The surgical management of intrathoracic pseudomyxoma peritonei

Author:

Ren Dewang1,Wang Zhiyuan1,Miao Libin1,Lu Weiqiang1,Ma Runyang1,Dou Xuejun1

Affiliation:

1. Aerospace Center Hospital

Abstract

Abstract Backgrounds: To explore the clinical features, diagnosis, treatment, and prognosis of intrathoracic pseudomyxoma peritonei. Methods: A retrospective analysis of the clinical findings pertaining to five intrathoracic pseudomyxoma peritonei patients that underwent surgical treatment at the Aerospace Center Hospital between March 2013 and May 2021 was conducted. All patients underwent thoracic cytoreductive surgery to resect all visible intrathoracic mucinous lesions, followed by regular follow-up to detect postoperative outcomes. Results: Four patients exhibited evidence of direct extension into the pleural cavity, and three underwent parietal/visceral pleurectomy to remove the mucinous tissue from the thoracic cavity to the greatest degree possible. One patient underwent the resection of disseminated pleural and lung lesions followed by hyperthermic intrathoracic chemotherapy (HITOC). One patient exhibited pulmonary metastases and underwent lobectomy. Macroscopic tumor resection was performed for all patients. Postoperative histopathology results from all five patients revealed a diagnosis of low-grade peritoneal pseudomyxoma arising from the appendix. One patient developed incomplete intestinal obstruction on day 5 post-surgery and was discharged following successful treatment. None of the included patients experienced operative mortality or serious postoperative complications. Patients were monitored for a mean follow-up interval of 22 months, and exhibited 1- and 3-year survival rates of 100% (5/5) and 40% (2/5), respectively. Conclusion: Intrathoracic pseudomyxoma peritonei is a rare clinical disease associated with a poor prognosis that primarily results following injury to the diaphragm during the surgical treatment of pseudomyxoma peritonei. Cytoreductive surgery to treat thoracic tumors in combination with HITOC can alleviate the symptoms of this condition and can contribute to better prognostic outcomes. However, it is important to remain attentive to the potential for perioperative complications.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3